Clostridioides difficileB

Xinchen Lv1,2,3,4, Yuanyuan Zhang3,5,6, Ke Sun3,4

  • 1Research Center for Industries of the Future, Westlake University, Hangzhou, Zhejiang, 310024, China.

Nature communications
|October 2, 2024
PubMed
概括

科学家们设计了新的微型蛋白质结合剂,可以中和Clostridioides difficile毒素B (TcdB) 变种. 这些泛特异性结合剂具有高亲和力,在体外和体内有效中和TcdB,为C. difficile感染 (CDI) 提供潜在的治疗策略.